Sources

9 Total Sources

AstraZeneca Drops 7% on Reported $400 Billion Bristol Myers Merger Talks

Left50%

Center25%

Right25%

AstraZeneca Stock Tumbles 7% Amid Reported Merger Talks with Bristol Myers Squibb

AstraZeneca Shares Drop 7% Amid $400 Billion Merger Talk Report with Bristol Myers Squibb

mix929.com20d ago

AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says | Mix 92.9 | Your Life, Your Music | Nashville, TN

AstraZeneca shares slide as Bristol Myers combination talks unsettle investors

Yahoo Finance20d ago

Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure?

Stocktwits20d ago

Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure?

Global Banking And Finance Review20d ago

AstraZeneca Shares Fall 7% After Bristol Myers Merger Talks Report

Business Standard20d ago

AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal | World News - Business Standard

Букви20d ago

AstraZeneca considers merger with Bristol Myers Squibb | Ukraine news - #Mezha